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Abstract
Background/objectives: Cardioprotective effects of Mediterranean-style diet have been shown. Instead of excluding
foods, replacement or addition may facilitate compliance with impact on glucose metabolism of individuals at
cardiometabolic risk. This study investigated the effect of changing selected nutrients intake on glucose metabolism
during a lifestyle intervention tailored to living conditions of prediabetic Brazilians.
Subjects/methods: 183 prediabetic adults treated under the Brazilian public health system underwent an 18-month
intervention on diet and physical activity. Dietary counseling focused on reducing saturated fat replaced by unsaturated
fatty acids. Data were collected at baseline and after follow-up. ANOVA and multiple linear regression were used to test
association of changes in nutrients intake with changes in plasma glucose.
Results: Changes in fasting and 2-h plasma glucose but not in weight, HOMA-IR or C-reactive protein decreased after
intervention across tertiles of MUFA changes (p-trend 0.017 and 0.024, respectively). Regression models showed that
increase in MUFA intake was independently associated with reduction in fasting (β -1.475, p = 0.008) and 2-h plasma
glucose (β -3.321, p = 0.007). Moreover, increase in soluble fibers intake was associated with decrease in fasting plasma
glucose (β -1.579, p = 0.038). Adjustment for anthropometric measurements did not change the results but did after
including change in insulin in the models.
Conclusions: Increases of MUFA and soluble fibers intakes promote benefits on glucose metabolism, independently of
adiposity, during a realistic lifestyle intervention in at-risk individuals. Mechanisms mediating these processes may
include mainly insulin sensitivity improvement.
Keywords: Monounsaturated fatty acids, Fiber intake, Lifestyle intervention, Glucose metabolism
Background
Obesity-related diseases, such as type 2 diabetes and car-
diovascular disease, are major preventable problems which
could be attenuated by a healthy diet and exercise [1,2].
However, long-term compliance with a healthy lifestyle is
a challenge, particularly in emerging countries, where po-
pulations have less access to healthy foods, usually more
expensive, and fewer opportunities for exercising. Dietary
recommendations have emphasized reduction in fat con-
sumption and encouraged fiber intake [3]. The deleterious
effects of saturated fatty acids (SFA) on cardiovascular risk
profile obfuscated the benefits of unsaturated fat, whose
cardioprotective role has been reinforced in more recent
publications [4,5]. Observational studies reported lower
cardiovascular mortality rates in populations consuming
high proportions of dietary unsaturated fatty acids and fi-
bers [6]. Underlying mechanisms involve inflammatory
mediators which interfere in glucose metabolism [7].
However, a diet rich in MUFA did not improve insulin
sensitivity in healthy participants of a Nordic randomized
clinical trial, except for a subgroup with a total fat in-
take < 37% of energy [8]. It remains unclear whether
beneficial effects on glucose metabolism are independent
of body weight [9,10]. Also, for cardiovascular prevention,
a mixture of soluble and insoluble fibers has been
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recommended. High-fiber diets have been associated with
benefits on glucose and lipid metabolism and may lower
risk of cardiovascular events [11]. Observational and
prospective studies provided evidence of improvement
in insulin sensitivity [12,13] but the effect of fibers on
inflammatory process is not yet well established [14].
Efficacy of the PREDIMED diet on reducing weight
gain [15] and preventing cardiometabolic outcomes [16]
has motivated several countries to change their eating
habits. Low acceptance of this dietary pattern outside
Mediterranean region was described in a Northern
European population [17]. In Latinos living in South
America, a better compliance with a diet rich in vegetable
oil, whole grains, fruits and vegetables, could be expected
considering their ancestry and local food availability.
Effectiveness of interventions on quality of fat and
amount of dietary fiber, tailored to public health systems
of developing countries, was scarcely investigated. In gen-
eral, dietary interventions imply food restrictions; instead
of excluding foods, replacement or even addition may be a
better strategy to achieve metabolic benefits. We hypothe-
sized that realistic changes in Brazilian eating habits may
facilitate compliance with impact on glucose metabolism
of individuals at cardiometabolic risk. This study investi-
gated the effect of changing selected nutrients intake on
glucose metabolism during a lifestyle intervention tailored
to living conditions of prediabetic Brazilians.
Subjects and methods
During 2008 and 2009, 438 individuals aged 18 to 79 years,
treated under the public health system of the São Paulo
city, Brazil, were screened for type 2 diabetes using a ques-
tionnaire adapted from the FINDRISC [18] and capillary
glycemia. Individuals who seek this assistance tend to have
low incomes and approximately 53% of the sample had up
to 8 years of schooling. Selected individuals were invited
to a clinical examination and laboratory tests including a
75-gram oral glucose tolerance test. Those with predia-
betes (impaired fasting glycemia or impaired glucose toler-
ance) [19] were invited to participate in 18-month lifestyle
interventions for diabetes prevention. Exclusion criteria
were overt diabetes, medical history of neurological or
psychiatric disturbances and thyroid, liver, renal and infec-
tious diseases. The Institutional Ethics Committee appro-
ved the study and written consent was obtained from all
participants. This trial was registered in the Brazilian
registry center of the WHO International Clinical Trials
Registry Platform (RBR #65 N292 at www.ensaiosclinicos.
gov.br).
From 230 eligible individuals, 183 agreed to participate
and 129 completed the intervention period until year
2010 (Figure 1). Among those who did not agree to
participate there was a predominance of men; baseline
socio-demographic, anthropometric and metabolic variables
of non-participants did not differ from participants. Data
of participants who were lost to follow-up were similar to
those who completed the study. Drop-outs were mainly
due to limited time to attend the visits during business
hours.
Study protocol
Participants were randomly assigned to one of two
18-month interventions on dietary habits and physical
activity. Both interventions have quarterly medical con-
sultations when counseling for changing lifestyle was rein-
forced but differed by the inclusion of psychoeducative
sessions [20,21]. Questionnaires and clinical data were
collected at baseline and after follow-up. Baseline clinical
data of the groups of participants were similar [22] and
also the effects of the two types of interventions were
comparable (data not shown). For the purpose of this
study, the total sample was analyzed independent of the
intervention type.
Dietary counseling was based on caloric restriction for
those with elevated body mass index, reduction in foods
rich in SFA (butter, whole milk and whole dairy products,
visible fatty from meats and cold meats) encouraging
those rich in unsaturated fatty acids (1 tablespoon of olive
oil at lunch and another at dinner every day, at least 2
servings of fish per week, nuts and avocado whenever pos-
sible), as well as on high intake of soluble and insoluble
fibers (at least 5 servings of fruits and vegetables per day,
1 or 2 servings of legumes and at least half of daily grains
from whole-grain sources). Intervention goals were SFA
intake ≤ 10% per day, total fiber intake ≥ 20 g/day, physical
activity ≥150 minutes/week and weight loss ≥ 5% when
indicated.
Three nonconsecutive 24-hour dietary recalls (two
weekdays and one weekend day) were obtained by trained
438 screened
230 eligible
183 accepted
129 completed the 18-month 
intervention programs
20.4% refused
27.3% lost to follow-up
1.6% incident cases of diabetes
0.5% deceased
Figure 1 Flowchart of individuals in each stage of the study.
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nutritionists, based in the USDA Multi-Pass Method [23].
The long version of the International Physical Activity
Questionnaire was employed to assess physical activity
level [24]. Blood pressure was measured at rest in sitting
position by an automatic blood pressure device (Omron
HEM-712C, Omron Health Care, USA). The average of
the last two recorded measurements was used in analyses.
Participants were submitted to a 75-gram oral glucose
tolerance test. Plasma glucose and lipoproteins were
immediately determined and aliquots were frozen at −80°C
for further determinations of inflammatory markers and
hormones. Ultra sensitivity C-reactive (CRP) and tumor
necrosis factor-alpha (TNF-α) concentrations were de-
termined by immunoenzyme chemiluminescent assay
(Immulite, Diagnostic Products Corporation, Los Angeles,
CA, USA) and insulin by immunometric assay (AutoDelfia,
Perkin Elmer Life Sciences Inc, Norton, OH, USA). Ho-
meostasis model assessment (HOMA-IR) was used to
assess insulin resistance [25].
Statistical analysis
Household measurements of foods were transformed
into measurement units and nutritional values calculated
using the Nutrition Data System for Research (Nutrition
Coordinating Center, Minneapolis, US). Participants with
energy intake < 500 kcal were excluded from the analysis
[26]. Mean nutrient intakes were expressed in grams and/
or percent of total energy intake (% E). Dietary data
were adjusted according to the method of Willett &
Stampfer [27].
Data were expressed as means and standard deviations
or percentages. Normality of variables was verified with
histogram and Kolmogorov-Smirnov test. When distri-
butions were skewed they were log-transformed before
analysis and values were back-transformed to return to
the natural scale. Student t test (or non-parametric equi-
valent) was used for comparisons of variables before and
after intervention and Pearson’s coefficient to test corre-
lations between changes in variables. Changes in nutri-
ent intake were categorized into tertiles; ANOVA with
Bonferroni’s method for pair comparisons was employed
to compare changes in plasma glucose across tertiles and
p-trend calculated. Dietary variables with a p-value <0.20
were selected for multivariate analysis. Stepwise linear
regression was used to analyze association with changes in
fasting or post-load plasma glucose (dependent variables),
with adjustments for age, sex, change in leisure physical
activity, change in SFA, family history of diabetes and type
of intervention. Also, weight or waist circumference, CRP
and insulin were included in final models to examine the
influence of body adiposity, inflammation and insulin re-
sistance mediating the relationship between dietary intake
and glucose homeostasis. Coefficients and 95% confidence
intervals were provided. Analyses were performed using
Statistical Package for Social Sciences version 17.0 for
Windows (SPSS Inc., Chicago, Illinois, USA). A p-value
of <0.05 was considered significant.
Results
Mean age of 183 participants (65% women) was 54.7 ±
12.3 years and 86% were overweight or obese at baseline.
After intervention, reductions in total energy (1.822 ± 679
to 1.542 ± 548 kcal/day, p < 0.01), carbohydrates (51.0 ±
6.9 to 49.6 ± 6.7% of energy, p = 0.036), added sugars
(36.8 ± 20.3 to 28.5 ± 20.8% of energy, p < 0.01) and
trans fatty acids (3.3 ± 2.3 to 2.6 ± 2.2 g, p < 0.01) intakes
were found, but not in unsaturated fat and fibers intakes
and physical activity level (Table 1). Additionally, decreases
in weight (78.7 ± 14.8 to 77.0 ± 14.9 kg, p < 0.01), waist
circumference (101.1 ± 13.0 to 98.7 ± 12.3 cm, p < 0.01),
mean blood pressure (109.7 ± 14.6 to 95.0 ± 10.1 mmHg,
p < 0.01), fasting plasma glucose (98.7 ± 11.5 to 95.9 ±
12.1 mg/dL, p = 0.029), LDL-c (130.2 ± 40.5 to 121.3 ±
40 mg/dL, p = 0.023), HOMA-IR (2.49 ± 1.81 to 1.66 ± 0.91,
p < 0.01) and inflammatory markers were detected as well
as increase in HDL-c (42.5 ± 12.5 to 49.5 ± 14.6 mg/dL,
p < 0.01).
In average, MUFA intake was the same after interven-
tion, since several participants increased but a propor-
tion decreased consumption. Changes in MUFA intake
were found to be inversely correlated to changes in
fasting (r = −0.286; p = 0.001) and 2-hour plasma glucose
(r = −0.222; p = 0.011) (Figure 2). Changes in other fatty
acids and other nutrients intakes were not significantly
correlated to changes in glucose levels.
Significant trends to reductions in fasting and 2-hour
plasma glucose after intervention across tertiles of MUFA
changes (p-trend = 0.017 and 0.024, respectively) were
verified but not in body weight, HOMA-IR or CRP con-
centration (Table 2). When stratifying according to tertiles
of SFA, trans fatty acids or of fiber intake changes, no
association was detected (data not shown).
In multiple linear regression, increase in MUFA in-
take was associated with reduction in fasting [ß −1.90
(95% CI −3.08; −0.72)] and 2-h plasma glucose [ß −3.55
(95% CI −6.30; −0.80 (−4.78; −0.62)], adjusted for age, sex,
change in leisure physical activity and in saturated fatty
acids, family history of diabetes, type of intervention and
changes in body weight, waist circumference and CRP
levels (Table 3, Model 1 + Change in C-reactive protein).
Moreover, increase in soluble fibers intake was independ-
ently associated with decrease in fasting plasma glucose
only [ß −1.53 (−3.04; −0.02)]. All other changes in dietary
variables were not associated with changes in plasma glu-
cose. Additional adjustments for anthropometric variables
changes did not modify the associations of MUFA and
soluble fibers with plasma glucose. On the other hand,
when changes in CRP were added, association of soluble
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fibers lost significance. Similarly, statistical significance dis-
appeared adding changes in insulin to model 1 of MUFA
and soluble fibers.
Discussion
This real-life lifestyle intervention in at-risk individuals
treated under the Brazilian public health system was able
to improve dietary habits, inducing benefits in cardiomet-
abolic profile. Our findings are relevant since they indicate
that benefits previously described in efficacy trials for dia-
betes prevention from developed countries [2,28] may be
feasible in developing countries where projection of this
disease is mainly alarming [29].
It was our interest to investigate which nutrients could
most contribute to the improvement of glucose metabolism
in order to orientate future public health policies. In agree-
ment with prospective studies involving Mediterranean-
style diets, our data on MUFA and soluble fiber intakes
suggested that even small increments in these nutrients
were able to induce favorable effects on glucose metabol-
ism [5,15,16].
In contrast to the usual concern regarding SFA recom-
mendation for individuals at high cardiovascular risk
[2,28], our most interesting finding was related to MUFA
intake. Although increased mean MUFA intake could
not be demonstrated in our sample, its protective effect
on glucose metabolism was consistently suggested in all
analyzes performed. The large intake range allowed exam-
ining how differences in MUFA intake were associated
with changes in clinical outcomes. Even after adjustment
for several variables, MUFA intake maintained associated
with reductions in plasma glucose levels. Each increment
of 5% energy of MUFA ingested results in −7.5 mg/dL
and −16.5 mg/dL decreases in fasting and 2-h plasma
glucose, respectively. We speculate that, in the long-term,
such glycemic decreases – even within the non-diabetic
Table 1 Mean (± standard deviation) of dietary, physical activity and clinical data of participants at baseline and after
intervention
Baseline After intervention P-value
• Daily habits variables
Energy (kJ and kcal/day) 7,626 ± 2,842 (1,822 ± 679) 6,455 ± 2,294 (1,542 ± 548) <0.001
Carbohydrate (% E) 51.0 ± 6.9 49.6 ± 6.7 0.036
Added sugar (g) 36.8 ± 20.3 28.5 ± 20.8 <0.001
Protein (% E) 17.9 ± 3.5 19.9 ± 4.1 <0.001
Total fat (% E) 31.4 ± 5.5 31.3 ± 5.6 0.847
Saturated fatty acids (% E) 9.7 ± 2.9 9.6 ± 2.7 0.658
Monounsaturated fatty acids (% E) 10.8 ± 2.6 10.8 ± 2.7 0.951
Polyunsaturated fatty acids (% E) 8.2 ± 2.1 8.1 ± 2.0 0.724
Trans fatty acids (g) 3.3 ± 2.3 2.6 ± 2.2 <0.001
Soluble fibers/1,000 kcal (g)* 2.4 ± 1.3 2.2 ± 1.6 0.099
Unsoluble fibers/1,000 kcal (g)* 6.9 ± 2.8 6.9 ± 3.7 0.222
Leisure physical activity (min/week)* 36.6 ± 66.3 46.4 ± 82.0 0.466
• Clinical variables
Body weight (kg) 78.7 ± 14.8 77.0 ± 14.9 <0.001
Waist circumference (cm) 101.1 ± 13.0 98.7 ± 12.3 <0.001
Mean blood pressure (mmHg) 109.7 ± 14.6 95.0 ± 10.1 <0.001
Fasting plasma glucose (mg/dL) 98.7 ± 11.5 95.9 ± 12.1 0.029
2-h plasma glucose (mg/dL) 117.5 ± 27.7 113.2 ± 30.5 0.111
Triglycerides (mg/dL) 157.3 ± 67.2 149.3 ± 81.3 0.191
LDL-cholesterol (mg/dL) 130.2 ± 40.5 121.3 ± 40.0 0.023
HDL-cholesterol (mg/dL) 42.5 ± 12.5 49.5 ± 14.6 <0.001
HOMA-IR* 2.49 ± 1.81 1.66 ± 0.91 <0.001
C-reactive protein (mg/dL)* 0.34 ± 0.24 0.04 ± 0.05 <0.001
Tumor necrosis factor-α (pg/dL)* 12.5 ± 6.3 10.4 ± 6.8 <0.001
Student t test; *Wilcoxon test.
E, total energy intake.
Individuals who were diagnosed with diabetes during the intervention period were excluded from this analysis.
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range – could have a beneficial role on the natural history
toward type 2 diabetes. Based on the observations that
cardiovascular outcomes occurred in a continuum [30],
the term dysglycemia – referring to near-normal fasting
plasma glucose levels – has been used [31]. In this early
stage, pathophysiological mechanisms, such as low-grade
inflammation and insulin resistance, contribute to increase
cardiometabolic risk.
Along the same line, clinical trials have previously
showed that substitution of SFA by MUFA improves
insulin sensitivity [8,32]. Accordingly, the PREDIMED
observed a 52% reduction in diabetes incidence among
individuals submitted to Mediterranean diets [5]. In our
multiple analysis, adjustment for change in insulin caused
loss of significance on the effect of MUFA intake, suggest-
ing that the beneficial effects on glucose metabolism may
occur via improvement on insulin sensitivity.
In insulin-resistant individuals with several metabolic
disturbances, a high-MUFA diet was considered a good
option for nutritional management of glucose and lipid
metabolism, as well as hepatic steatosis [33,34]. Despite
lack of MUFA increase, our intervention was able to
reduce HOMA-IR, concomitantly with improvement in
plasma glucose and lipids levels. This nutrient is shown
to affect cell membrane fatty acids composition and
function, including changes in membrane fluidity, ion
permeability and insulin receptor affinity, which could
enhance glucose uptake [35]. Animal studies described
contrasting effects SFA and MUFA enriched diets on
GLUT4 translocation and provided evidence on possible
mechanisms explaining their impact on glucose metabol-
ism [36,37]. MUFA-induced improvement in insulin sen-
sitivity seemed to be associated with a preserved IRS-1/
PI3K insulin signaling. Considering that this pathway is
known to be influenced by inflammatory mediators, we
expected that this nutrient could attenuate circulating
levels of CRP and/or TNF-α [38]. This hypothesis was not
supported in our study since adjusting for CRP changes
did not interfere on the MUFA impact in plasma glucose.
How dietary fatty acids composition modifies insulin sen-
sitivity in humans requires further investigations using
more appropriate study design.
r = -0.286
p =0.001
r = - 0.222
p =0.011
A B
Figure 2 Correlation of changes in MUFA with changes in fasting (panel A) and post-load plasma glucose (panel B). MUFA –
monounsaturated fatty acids. Pearson correlation test.
Table 2 Mean values of changes in clinical variables across tertiles of changes in MUFA intake (% energy)
Tertile 1 Tertile 2 Tertile 3 P-trend
−6.6 to −1.3 −1.3 to 1.1 1.1 to 7.0
Change in weight (kg) −2.5 ± 4.0 −1.0 ± 3.8 −1.4 ± 3.8 0.151
Change in fasting plasma glucose (mg/dL) 3.1 ± 18.0 −1.6 ± 16.1 −6.9 ± 13.3Ɨ 0.017
Change in 2-h plasma glucose (mg/dL) 3.1 ± 40.1 5.9 ± 31.6 −13.5 ± 33.2θ 0.024
Change in HOMA-IR −1.1 ± 1.9 −0.8 ± 1.5 −0.6 ± 1.5 0.448
Change in C-reactive protein (mg/dL) −0.32 ± 0.23 −0.25 ± 0.19 −0.30 ± 0.24 0.273
ANOVA and Bonferroni’s method for pair comparisons.
Ɨp < 0.05 vs. tertile 1 θp < 0.05 vs. tertile 2.
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In multiple linear regression, the cardiometabolic pro-
tective role of dietary fiber was also explored. Such ana-
lysis indicated that each increment of 5 gram of soluble
fibers ingested should result in a reduction of 8 mg/dL
in fasting plasma glucose. Increase in fiber intake was a
goal of our intervention [3,39]. In agreement with our
results, an analysis of a subset of participants of the
PREDIMED study showed that reductions on fasting
glucose were higher among individuals in the upper 20%
of fiber intake [40]. Despite the health benefits of fiber
have been consistently demonstrated, there are still con-
troversies on which fiber type has the most protective
role on diabetes prevention [41,42].
Fiber-rich diets are usually less energy dense, richer in
micronutrients, and bring a feeling of satiety sooner
[39]. In relation to benefits of soluble fibers on the glucose
metabolism, it has been proposed that their viscosity con-
tributes to slow gastric emptying rates, digestion and the
absorption of glucose, consequently reducing glycemic
excursion and insulin secretion. The stability of plasma
glucose and insulin levels may potentially contribute to
enhancing peripheral insulin sensitivity [39,43]. More-
over, effects induced by the presence of fiber in the
stomach and duodenum interfere in glucagon-like peptide
1 secretion, which could affect not only insulin release,
but also insulin sensitivity [44]. In the present study, the
loss of significance of soluble fibers after adjustment for
change in insulin concentration reinforces that this nu-
trient improve plasma glucose by interfering on insulin
release and/or action. Furthermore, adjusting for change
in CRP, the effect the soluble fibers was lost, suggesting
that such benefit could be occurring via systemic in-
flammation. In fact, anti-inflammatory effect of fiber
was previously reported [45], as well as the deterior-
ation of insulin sensitivity induced by low-grade inflam-
mation [46].
Noteworthy, the effects of soluble fibers and MUFA in-
take were not modified after addition of variables change
in weight or in waist circumference in the models, support-
ing that the reduction in adiposity may not be the main
factor responsible for the dietary-induced benefits on glu-
cose metabolism found in the current study. In agreement
with our findings, an intervention with Mediterranean diet
(>40% of energy from fat and non-energy-restricted), with-
out specific orientation to weight loss, reduced the fre-
quencies of metabolic disturbances [47].
Although the reduction in SFA intake has been recom-
mended to improve insulin sensitivity, association between
Table 3 Association coefficients between intervention-induced changes in nutrients intake and in fasting and 2-h
plasma glucose
Change in fasting plasma glucose Change in 2-h plasma glucose
ß (95% CI) p-value ß (95% CI) p-value
Crude
Change in MUFA (% E) −1.58 (−2.51; −0.65) 0.001 −2.70 (−4.78; −0.62) 0.011
Change in soluble fibers (g) −0.45 (−1.71; 0.81) 0.481 −1.24 (−4.01; 1.54) 0.379
Model 1
Change in MUFA (% E) −1.48 (−2.55; −0.40) 0.008 −3.32 (−5.71; −0.93) 0.007
Change in soluble fibers (g) −1.58 (−3.07; −0.09) 0.038 −1.88 (−5.19; 1.44) 0.264
Model 1 + Change in weight
Change in MUFA (% E) −1.48 (−2.57; −0.39) 0.008 −3.44 (−5.85; −1.04) 0.005
Change in soluble fibers (g) −1.57 (−3.08; −0.06) 0.041 −1.71 (−5.05; 1.63) 0.311
Model 1 + Change in waist circumference
Change in MUFA (% E) −1.52 (−2.61; −0.42) 0.007 −3.68 (−6.07; −1.30) 0.003
Change in soluble fibers (g) −1.53 (−3.04; −0.02) 0.047 −1.57 (−4.77; 1.23) 0.378
Model 1 + Change in C-reactive protein
Change in MUFA (% E) −1.90 (−3.08; −0.72) 0.002 −3.55 (−6.30; −0.80) 0.012
Change in soluble fibers (g) −1.28 (−2.89; 0.33) 0.825 −2.54 (−6.28; 1.20) 0.181
Model 1 + Change in 2-h insulin
Change in MUFA (% E) −0.54 (−2.85; 1.76) 0.631 −3.20 (−8.27; 1.87) 0.205
Change in soluble fibers (g) −0.84 (−3.45; 1.76) 0.719 0.20 (−5.13; 5.93) 0.943
Multiple linear regression analysis.
CI, confidence interval; MUFA, monounsaturated fatty acids; E, total energy intake.
Model 1: age, sex, change in leisure physical activity, change in saturated fatty acids, family history of diabetes (no or yes), type of intervention.
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change in SFA and change in plasma glucose was not
found in the present study. Our results are in agreement
with the LIPGENE which did not find beneficial effect
on insulin sensitivity after reducing the amount of this
type of fat [48].
On daily basis, soluble fibers and MUFA intake could
be increased by the consumption of oat and olive oil.
According to our findings, addition of two tablespoons
of olive oil (26 g = 19 g of MUFA = 8.6% of total energy
intake) in a 2000 kcal diet would reduce fasting plasma
glucose in 12.7 mg/dL and 2-hour glucose in 28.6 mg/dL.
Similarly, adding two tablespoons of oats (30 g = 1.74 g of
soluble fibers) would decrease fasting plasma glucose in
2.7 mg/dL. Both changes would be able, therefore, to
reduce fasting glucose in 15.4 mg/dL and 2 h-plasma glu-
cose in 28.6 mg/dL. We believe that these changes in the
eating habits are feasible, even in middle-income coun-
tries. Adding a new food in dietary plan may be easier
than restricting (such as restriction of SFA sources). Also,
we speculate that soluble fibers and MUFA-rich foods in
the meals could enhance satiety minimizing energy intake
and facilitating body weight control.
Other mechanisms have been more recently proposed
to explain relationships between diet changing and glucose
metabolism, which might be mediated by the gut micro-
biota [49]. Understanding how dietary changes could shape
this microbial ecosystem and then interact with host’s
metabolism altering insulin sensitivity may contribute
to orient lifestyle interventions.
Our study has limitations; some are related to intrinsic
weakness of the available techniques to quantify food
intake. However, several precautions were taken to im-
prove the accuracy of the dietary data collected. We can-
not exclude that different populations respond distinctly
to the same nutrient modification in part due to genetic
characteristics. Our study did not include a large sample,
but has the strength of having a longitudinal design,
conducted in an at-risk miscigenated population of a
developing country. Despite the MUFA intake have not
been an intervention goal, our results call attention to
the importance of this fatty acid in the context of fat in-
take recommendations to individuals at cardiometabolic
risk. Further lifestyle interventions designed for high-risk
populations should consider increasing MUFA intake as
dietary goal.
In summary, we conclude that increases of MUFA
and soluble fibers intakes promote benefits on glucose
metabolism, independently of adiposity, during a realistic
lifestyle intervention in at-risk individuals. Possible
mechanisms mediating these processes may mainly in-
clude improvement in insulin sensitivity. Encouraging
fiber and MUFA intakes may be a good strategy for
at-risk individuals without necessarily restricting energy
consumption.
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